Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This study will measure the effect of the anti-diabetic agent sitagliptin on blood pressure
in individuals with the metabolic syndrome. We will also measure the effect of sitagliptin on
blood pressure in people already taking a blood pressure medication called an ACE inhibitor.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center